86.22.Z - Specialist medical practice
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.73.Z - Retail sale of pharmaceutical products
72.19.Z - Scientific research and development activities
82.30.Z - Activities related to organizing fairs, exhibitions, and congresses
86.10.Z - Hospital activities
86.21.Z - General medical practice
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 2,2 | 3 | 2,7 | -11,1 |
EBITDA | 4,2 | 5,4 | 5,2 | -3,3 |
Short time liabilities | 3,1 | 3,4 | 4,7 | 39,7 |
Equity capital | 7,2 | 9,2 | 10,3 | 12,4 |
Operating profit (EBIT) | 2,3 | 3,3 | 3 | -9,9 |
Assets | 14,3 | 15,4 | 17,4 | 12,9 |
Net profit (loss) | 2,2 | 2,7 | 2,5 | -9,3 |
Cash | 2,7 | 3,9 | 4,6 | 16,8 |
Net income from sale | 25,6 | 32,2 | 37 | 15,1 |
Liabilities and provisions for liabilities | 7,1 | 6,3 | 7,1 | 13,7 |
Working assets | 5,4 | 6,2 | 8,5 | 36,6 |
Depreciation | 1,9 | 2 | 2,2 | 7,4 |
% | % | % | p.p. | |
Profitability of capital | 31 | 29,6 | 23,9 | -5,7 |
Equity capital to total assets | 50,2 | 59,4 | 59,2 | -0,2 |
Gross profit margin | 8,6 | 9,5 | 7,3 | -2,2 |
EBITDA Margin | 16,5 | 16,7 | 14 | -2,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 44 | 39 | 47 | 8 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane